Doç. Dr. Sabahat ÇEKEN

1. Bloodstream infections in older cancer patients: epidemiology and risk factors for mortality

ÇEKEN S., Yılmaz N., Hekimoğlu C. H., Toros G. Y., Güleşen A. İ., Savaş E. M., et al.

Journal of Infection in Developing Countries , cilt.19, sa.8, ss.1205-1215, 2025 (SCI-Expanded, Scopus)

2. The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data

GÜRBÜZ Y., Kocagül-çelikbaş A., ÖZTOPRAK ÇUVALCI N., AYGEN B., BATIREL A., Habiloğlu A. D., et al.

Infectious Diseases and Clinical Microbiology , cilt.6, sa.3, ss.216-224, 2024 (ESCI, Scopus, TRDizin)

3. Evaluation of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus seroprevalence in patients with diffuse large B cell lymphoma and Hodgkin’s lymphoma

MERT D., Merdin A., ÇEKEN S., DAL M. S., ERTEK M., ALTUNTAŞ F.

Journal of Cancer Research and Therapeutics , cilt.17, sa.4, ss.951-955, 2021 (SCI-Expanded, Scopus)

4. Evaluation of risk factors and causative pathogens in bloodstream infections in cancer patients

Mert O. D., Merdin A., Kandemir N., KIZIL ÇAKAR M., Dirim E., ÇEKEN S., et al.

Gulhane Medical Journal , cilt.63, sa.1, ss.42-51, 2021 (Scopus, TRDizin)

5. Epidemiology of geriatric infections and factors affecting mortality Geriatrik enfeksiyonların epidemiyolojisi ve mortaliteye etkili faktörler

ÇEKEN S., MERT D., Toros G. Y., Kolukisa Y., GEDİK H., İSKENDER G., et al.

Turk Hijyen ve Deneysel Biyoloji Dergisi , cilt.78, sa.4, ss.545-554, 2021 (Scopus, TRDizin)

6. Evaluation of Risk Factors for Mortality in Febrile Neutropenia

ÇEKEN S., GEDİK H., İSKENDER G., Demirelli M., MERT D., Toros G. Y., et al.

Journal of Infection in Developing Countries , cilt.14, sa.8, ss.886-892, 2020 (SCI-Expanded, Scopus)

7. Hepatitis C screening and referral for further investigation and treatment in a tertiary care hospital

İSKENDER G., MERT D., ÇEKEN S., BAHÇECİTAPAR M., Yenigün A., ERTEK M.

Journal of Infection in Developing Countries , cilt.14, sa.6, ss.642-646, 2020 (SCI-Expanded, Scopus)

8. Development of pneumonitis after rituximab treatment in a patient with lymphoma

MERT D., Merdin A., ÇEKEN S., Sinan Dal M., ERTEK M., ALTUNTAŞ F.

Journal of Oncology Pharmacy Practice , cilt.26, sa.4, ss.1009-1010, 2020 (SCI-Expanded, Scopus)

9. The isolated bacteria from culture and antibiotic susceptibilities in urinary tract infections I˙drar yolu enfeksiyonlarinda kültürden izole edilen bakteriler ve antibiyotik duyarliliklari

MERT D., ÇEKEN S., ERTEK M.

Turk Hijyen ve Deneysel Biyoloji Dergisi , cilt.77, sa.1, ss.25-32, 2020 (Scopus)

10. Epidemiology and mortality in bacterial bloodstream infections in patients with hematologic malignancies

MERT D., ÇEKEN S., İSKENDER G., İSKENDER D., Merdin A., Duygu F., et al.

Journal of Infection in Developing Countries , cilt.13, sa.8, ss.727-735, 2019 (SCI-Expanded, Scopus)

11. Awareness of hepatitis b virus reactivation among physicians administering immunosuppressive treatment and related clinical practices İmmünosüpresif tedavi veren hekimlerin hepatit b virusu reaktivasyonuyla ilgili farkındalıklarının ve klinik pratiklerinin değerlendirilmesi

Korkmaz P., Demirtürk N., ÇINAR G., ÇEKEN S., AYGEN B., TOKA O., et al.

Klimik Dergisi , cilt.32, sa.2, ss.146-153, 2019 (Scopus)

12. Agreement between QuantiFERON-TB gold in-tube and tuberculin skin tests in hematopoietic stem cell transplantation candidates Hematopoetik Kök Hücre Nakli Adaylarında QuantiFERON-TB Gold In-tube ve Tüberkülin Deri Testi Arasındaki Uyum

Yapar Toros G., ÇEKEN S., Sezen F., GEDİK H., DAL M. S., ERTEK M., et al.

Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.8, 2019 (Scopus)

13. Hepatitis B virus reactivation in patients with hematological malignancies under lamivudine prophylaxis

İSKENDER G., ÇEKEN S., Ogan M. C., Kayikci O., GEDİK H., Tekgunduz E., et al.

Acta Medica Mediterranea , cilt.35, sa.5, ss.2417-2422, 2019 (SCI-Expanded, Scopus)

14. Risk factors for bloodstream infections due to extended-spectrum β-lactamase producing enterobacteriaceae in cancer patients

ÇEKEN S., İSKENDER G., GEDİK H., Duygu F., MERT D., Kaya A. H., et al.

Journal of Infection in Developing Countries , cilt.12, sa.4, ss.265-272, 2018 (SCI-Expanded, Scopus)

15. BK virus-associated hemorrhagıc cystitis in patients wıth allogeneıc hematopoıetıc cell transplantation: Report of three cases

MERT D., BATGİ H., Merdin A., ÇEKEN S., Dal M. S., Tekgündüz E., et al.

Hematology Reports , cilt.9, sa.2, 2017 (Scopus)

16. Evaluation of epidemiological characteristics, risk factors and antifungal sensitivity of candidemia cases in a tertiary-care hospital

MERT D., Yilmaz G. R., ÇEKEN S., İSKENDER G., Yenigün A., ERTEK M.

Acta Medica Mediterranea , cilt.33, sa.5, ss.815-820, 2017 (SCI-Expanded, Scopus)

17. Clinical characteristics and effect of early treatment in tularemia cases

İSKENDER G., ÇEKEN S., GEDİK H., Ogan M. C., KILIÇ S., ERTEK M.

Acta Medica Mediterranea , cilt.32, sa.2, ss.391-397, 2016 (SCI-Expanded, Scopus)

Doç. Dr. Sabahat ÇEKEN

Yayınlar & Eserler

1. Bloodstream infections in older cancer patients: epidemiology and risk factors for mortality

2. The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data

3. Evaluation of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus seroprevalence in patients with diffuse large B cell lymphoma and Hodgkin’s lymphoma

4. Evaluation of risk factors and causative pathogens in bloodstream infections in cancer patients

5. Epidemiology of geriatric infections and factors affecting mortality Geriatrik enfeksiyonların epidemiyolojisi ve mortaliteye etkili faktörler

6. Evaluation of Risk Factors for Mortality in Febrile Neutropenia

7. Hepatitis C screening and referral for further investigation and treatment in a tertiary care hospital

8. Development of pneumonitis after rituximab treatment in a patient with lymphoma

9. The isolated bacteria from culture and antibiotic susceptibilities in urinary tract infections I˙drar yolu enfeksiyonlarinda kültürden izole edilen bakteriler ve antibiyotik duyarliliklari

10. Epidemiology and mortality in bacterial bloodstream infections in patients with hematologic malignancies

11. Awareness of hepatitis b virus reactivation among physicians administering immunosuppressive treatment and related clinical practices İmmünosüpresif tedavi veren hekimlerin hepatit b virusu reaktivasyonuyla ilgili farkındalıklarının ve klinik pratiklerinin değerlendirilmesi

12. Agreement between QuantiFERON-TB gold in-tube and tuberculin skin tests in hematopoietic stem cell transplantation candidates Hematopoetik Kök Hücre Nakli Adaylarında QuantiFERON-TB Gold In-tube ve Tüberkülin Deri Testi Arasındaki Uyum

13. Hepatitis B virus reactivation in patients with hematological malignancies under lamivudine prophylaxis

14. Risk factors for bloodstream infections due to extended-spectrum β-lactamase producing enterobacteriaceae in cancer patients

15. BK virus-associated hemorrhagıc cystitis in patients wıth allogeneıc hematopoıetıc cell transplantation: Report of three cases

16. Evaluation of epidemiological characteristics, risk factors and antifungal sensitivity of candidemia cases in a tertiary-care hospital

17. Clinical characteristics and effect of early treatment in tularemia cases

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Proje

Açık Erişim